Frontlight ResearchEarly access
CompletedNo phase
redoPOEM : Failure of a First POEM
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- France14 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 111 people enrolled
- Started
- 3 Oct 2023
- Ended
- 28 Feb 2024
- Type of study
- Observational
- Record updated
- 10 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- adult patient
- diagnosis of achalasia based on clinical criteria according to Eckardt score, manometry, and radiology when available
- failure after POEM (Eckardt score > or equal to 4 in consultation) treated with a new POEM
- no active digestive neoplasia
Who cannot take part
- Technical failure of redoPOEM
- Person not affiliated to a Social Security scheme
- Language barrier preventing fair collection of non-opposition
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
observational study, measurement of efficacy in the cohort.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety After Failure of a First POEM
- Publications
- RedoPOEM: efficacy and safety after failure of a first POEM for esophageal motility disorders.Surgical endoscopy, 2026
- Record updated
- 10 July 2024